Cuthbert Simpkins on reducing the bioavailability of nitric oxide to improve patient survival
Cuthbert Simpkins, President and Chief Innovation Officer at Vivacelle Bio, Inc. talks to us about the origin of Vivacelle Bio. He mentions how despite being able to fix physical injury, death can still occur due to an overproduction of nitric oxide, which acts as a blood vessel dilator. Stopping nitric oxide from being produced, clamps down blood flow allowing a better chance of survival. The challenge is to reduce the bioavailability of nitric oxide, while at the same time allowing its production.